Treatment of taeniasis and cysticercosis with praziquantel and albendazole
Abstract: Recent methods,
doses and results of medical treatment on taeniasis/cysticercosis, a zoo-notic
parasitic disease caused by Taenia solium and Taenia saginata are discussed. In
cases of cysticercosis T. solium, especially neurocysticercosis the optimal length
and dose of albendazole is a course of 8 days with doses of 15 mg/kg/day
divided in two times added by 50 mg/day of prednisone in the morning. The drug
is effective in almost any location of the parasites for 80-90% of macroscopic
cysts seen by imaging studies. For taeniasis a single dose of praziquantel,
10-15 mg/kg achieves cure rates of more than 90%. Side effects such as nausea,
headache and abdominal pain are mild.
Evaluation of drug treatment is done by clinical, radiological and
serological evaluation. In Papua (=Irian Jaya) nine cases with suspected
neurocysticercosis, serologically positive, were treated with 1200 mg single
dose albendazole for 15 days. Prednisone tablets, three times daily one tablet,
5 mg during 7 days were added. After one year 6 cases were still serologic
positive. At the same time praziquantel, 1200 mg, single dose was given to ten
cases during 15 days and prednisone tablets, 3 times daily one tablet, 5 mg
during 7 days. After one year 5 sero-positive cases were still found. Albendazole
and praziquantel are both effective drugs for taeniasis and cysticercosis, with
minor side effects. In addition symptomatic treatment should be given if
necessary.
Author: Abdulbar Hamid, Sri S.
Margono, Toni Wandra, Akira Ito
Journal Code: jpkedokterangg050146

Artikel Terkait :
Jp Kedokteran gg 2005
- The benefits of progesterone therapy in imminent abortion
- PM10 as Predictor of Ventilation Efficiency of Houses in Relation to Health Effect
- Fatty acids intake among diverse ethnic groups in Indonesia
- The effects of balanced low calorie diet on body composition and serum leptin of obese women
- QT dispersion, a simple tool to predict ventricular tachyarrhythmias and/or sudden cardiac death after myocardial infarction
- Endoscopical appearances of nonsteroidal anti inflammatory drug (NSAID)- enteropathy
- Role of general practitioner in the management of acute myocardial infarction
- Genotyping of hepatitis B virus from dried and stored serum on filter paper
- Development of bioassay for pathogenecity testing of Ureaplasma urealyticum as part of host-pathogen communication
- Detection of GAD65 autoantibodies of type-1 diabetes using anti-GAD65-abs reagent produced from bovine brain tissue
- The use of ceftriaxone impregnated beads in the management of chronic osteomyelitis
- The correlation between total lymphocyte count and the number of candida colony from the oral cavity in HIV/AIDS patients
- Survival rate and prognostic factors in advanced cervical cancer patients accompanied by renal impairment
- Left ventricular diastolic dysfunction in type 2 diabetes mellitus patient without cardiovascular disease: the association with microalbuminuria
- Hormonal contraception as a risk factor for obesity
- Effect of irrigating fluid temperature on core body temperature during transurethral resection of the prostate
- T-lineage blast crisis of chronic myelogenous leukemia: simple record of 4 cases
- Intracranial germ cell tumour with extra cranial extension in a four month old infant – a case report
- Drospirinone: new generation of progestogen
- Implementation of 25-well culture plates for M. tuberculosis drug susceptibility testing in Indonesia
- Cytosolic estrogen and progesterone receptor content in the endometriotic tissues and endometrium in women with and without endometriosis
- Nutritional status of hyperlipidemics elderly in Indonesia according to body mass lndex (study in four Indonesian big cities)
- Age, duration of work, noise and vibration in inducing hearing and balance impairments
- Presurgical cytologic diagnostic test of uterine cavity in ovarian malignant tumor